GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (ROCO:4743) » Definitions » Price-to-Free-Cash-Flow

Oneness Biotech Co (ROCO:4743) Price-to-Free-Cash-Flow : N/A (As of May. 28, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Oneness Biotech Co Price-to-Free-Cash-Flow?

As of today (2025-05-28), Oneness Biotech Co's share price is NT$59.30. Oneness Biotech Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.70. Hence, Oneness Biotech Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Oneness Biotech Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Oneness Biotech Co's highest Price-to-Free-Cash-Flow Ratio was 44181.95. The lowest was 497.99. And the median was 647.03.

ROCO:4743's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.63
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Oneness Biotech Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was NT$-0.10. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$-0.70.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 0.70% per year.

During the past 13 years, Oneness Biotech Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 29.30% per year. The lowest was -67.90% per year. And the median was -7.50% per year.


Oneness Biotech Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Oneness Biotech Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Price-to-Free-Cash-Flow Chart

Oneness Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,263.89 - - - -

Oneness Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oneness Biotech Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Oneness Biotech Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's Price-to-Free-Cash-Flow falls into.


;
;

Oneness Biotech Co Price-to-Free-Cash-Flow Calculation

Oneness Biotech Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=59.30/-0.699
=N/A

Oneness Biotech Co's Share Price of today is NT$59.30.
Oneness Biotech Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.70.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Oneness Biotech Co  (ROCO:4743) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Oneness Biotech Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Section. 1, Zhongxiao West Road, No. 66, 35th Floor, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The company's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, OB318, and others. Along with its subsidiaries, the company operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation segment.

Oneness Biotech Co Headlines

No Headlines